MARKET INTRODUCTION
Anorexiants are drugs that act on the central nervous system to suppress the individual's appetite. They have a stimulating effect on the hypothalamic and limbic regions. Anorexiants suppress the appetite hence are used as therapy for obesity. Anorexiants increases the basal metabolic rate of the individual. Anorexiants also increase the cellular uptake of glucose and also it diminishes the dietary fat absorption.
MARKET DYNAMICS
The Anorexiants market is anticipated to grow in the forecast period owing to the rising obese population in various countries. Moreover, rising government awareness programs related to health issues associated with obesity is expected to amplify the demand for anorexiants market.
MARKET SCOPE
The "Global Anorexiants Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anorexiants market with detailed market segmentation by drug classification, route of administration, end user and geography. The global Anorexiants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Anorexiants market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Anorexiants market is segmented on the basis of drug classification, route of administration and end user. Based on drug classification, the market is segmented into Catecholamines Anorexiants and Serotonin Anorexiants. Based on Route of Administration, the market is segmented into Oral and Subcutaneous. On the basis of End User the market is segmented into hospitals, retail pharmacies and online.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Anorexiants market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anorexiants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Anorexiants market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anorexiants market in these regions.

MARKET PLAYERS
The report covers key developments in the Anorexiants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Anorexiants market are anticipated to lucrative growth opportunities in the future with the rising demand for Anorexiants market in the global market. Below mentioned is the list of few companies engaged in the Anorexiants market.
The report also includes the profiles of key Anorexiants market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Akrimax Pharmaceuticals, LLC
- Teva Pharmaceuticals
- Roche Pharmaceuticals
- Arena Pharmaceuticals GmbH
- Novo Nordisk A/S
- Abbott Pharmaceuticals
- Epic Pharma, LLC
- Patheon Pharmaceuticals Inc.
- Recordati Rare Diseases Inc.
- MOVA Pharmaceuticals.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.